AAPL 250.9362 1.1636% MSFT 439.85 0.5624% NVDA 132.26 2.5987% GOOGL 190.36 1.0403% GOOG 191.585 0.7547% AMZN 224.7026 1.8967% META 605.1 1.3245% AVGO 221.57 -0.9167% TSLA 434.8 -1.211% TSM 195.3 -0.133% LLY 758.87 -0.7637% V 315.9 1.9756% JPM 234.325 1.7168% UNH 493.79 -1.1867% NVO 103.7 -2.1329% WMT 93.89 0.3634% LVMUY 130.52 0.7721% XOM 105.67 -0.7048% LVMHF 649.5 0.6649% MA 526.755 1.3068%

Pennant Group Inc

Healthcare US PNTG

27.54USD
-0.61(2.17%)

Last update at 2024-12-19T18:50:00Z

Day Range

27.3828.43
LowHigh

52 Week Range

10.3124.06
LowHigh

Fundamentals

  • Previous Close 28.15
  • Market Cap719.60M
  • Volume90823
  • P/E Ratio43.55
  • Dividend Yield-%
  • EBITDA33.91M
  • Revenue TTM575.34M
  • Revenue Per Share TTM19.22
  • Gross Profit TTM 103.15M
  • Diluted EPS TTM0.55

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 8.89M 2.73M 17.90M 5.26M 20.63M
Minority interest -0.60000M 0.55M -0.19100M 4.59M 9.43M
Net income 6.64M 2.15M 15.74M 2.55M 15.68M
Selling general administrative 33.98M 36.26M 31.30M 35.13M 18.84M
Selling and marketing expenses - - - - -
Gross profit 58.59M 45.74M 54.89M 44.62M 42.44M
Reconciled depreciation 4.90M 4.78M 4.67M 3.81M 2.96M
Ebit 19.67M 4.70M 18.92M 5.67M 20.63M
Ebitda 24.57M 9.46M 23.82M 9.48M 23.59M
Depreciation and amortization 4.90M 4.76M 4.90M 3.81M 2.96M
Non operating income net other - - - - 0.00000M
Operating income 19.67M 4.70M 18.92M 5.67M 20.63M
Other operating expenses 453.54M 435.00M 372.04M 332.86M 265.43M
Interest expense 3.82M 1.94M 1.24M 0.41M 0.00000M
Tax provision 1.65M 0.58M 2.35M 2.08M 4.35M
Interest income - - - 0.41M -
Net interest income -3.81600M -1.94100M -1.23900M -0.41000M -
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense 1.65M 0.58M 2.35M 2.08M 4.35M
Total revenue 473.24M 439.69M 390.95M 338.53M 286.06M
Total operating expenses 38.88M 41.04M 35.97M 38.95M 21.81M
Cost of revenue 414.66M 393.96M 336.06M 293.92M 243.62M
Total other income expense net -10.78100M -1.96500M -1.01400M -0.41000M -0.75600M
Discontinued operations - - - - 0.00000M
Net income from continuing ops 7.24M 2.15M 15.55M 3.17M 16.28M
Net income applicable to common shares 6.64M 2.70M 15.74M 2.55M 15.68M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 539.69M 512.12M 530.30M 506.98M 447.75M
Intangible assets 67.74M 58.62M 53.73M 47.49M 33.51M
Earning assets - - - - -
Other current assets 12.90M 18.32M 16.71M 12.34M 6.10M
Total liab 394.18M 386.46M 416.05M 405.80M 376.64M
Total stockholder equity 140.34M 121.01M 110.20M 96.58M 71.11M
Deferred long term liab - - - - -
Other current liab 41.93M 38.38M 37.30M 41.11M 28.32M
Common stock 0.03M 0.03M 0.03M 0.03M 0.03M
Capital stock 0.03M 0.03M 0.03M 0.03M 0.03M
Retained earnings 34.66M 21.28M 14.64M 11.95M -3.79900M
Other liab - 6.28M 5.29M 11.90M 2.88M
Good will 91.01M 79.50M 74.27M 66.44M 41.23M
Other assets - 12.69M 8.68M 315.56M 3.40M
Cash 6.06M 2.08M 5.19M 0.04M 0.40M
Cash and equivalents - - - - -
Total current liabilities 71.55M 70.25M 71.64M 89.02M 51.19M
Current deferred revenue 1.66M 1.59M 7.67M 24.04M 1.94M
Net debt 323.57M 324.49M 350.05M 318.95M 334.45M
Short term debt 17.12M 16.63M 16.12M 14.11M 12.29M
Short long term debt - - - - -
Short long term debt total 329.63M 326.57M 355.24M 319.00M 334.86M
Other stockholder equity 105.65M 99.70M 95.53M 84.61M 74.88M
Property plant equipment - 26.62M 317.79M 17.88M 330.97M
Total current assets 80.08M 73.82M 75.84M 59.60M 38.68M
Long term investments - - - - -
Net tangible assets - -17.10200M -17.79600M -17.35300M -3.58400M
Short term investments - - - - -
Net receivables 61.12M 53.42M 53.94M 47.22M 32.18M
Long term debt 63.91M 62.89M 51.37M 8.28M 18.53M
Inventory - - - - -
Accounts payable 10.84M 13.65M 10.55M 9.76M 8.65M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - 4.64M 4.04M 4.59M -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.00000M - - - -11.78400M
Additional paid in capital - - - - -
Common stock total equity - 0.03M 0.03M 0.03M 0.03M
Preferred stock total equity - - - - -
Retained earnings total equity - 21.28M 14.64M 11.95M -
Treasury stock - - -0.06500M -0.06500M -
Accumulated amortization - - - - -
Non currrent assets other 9.34M 10.54M 4.83M 4.81M 3.35M
Deferred long term asset charges - - - - -
Non current assets total 459.61M 438.30M 454.46M 447.38M 409.07M
Capital lease obligations 265.72M 263.68M 303.87M 310.72M 316.33M
Long term debt total - 62.89M 51.37M 8.28M 18.53M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -24.23900M -20.12000M -41.61600M -26.46500M -9.47700M
Change to liabilities 4.56M 0.56M 16.03M 4.07M 1.37M
Total cashflows from investing activities -24.23900M -20.12000M -41.61600M -26.46500M -9.47700M
Net borrowings 11.00M 44.00M -10.57800M 20.00M 20.00M
Total cash from financing activities 12.08M 43.49M -8.94700M 17.27M -13.79300M
Change to operating activities -5.30000M -30.60900M 37.67M 2.67M 2.50M
Net income 7.24M 2.15M 15.55M 3.17M 16.28M
Change in cash -3.11100M 5.15M -0.35900M 0.36M 0.00500M
Begin period cash flow 5.19M 0.04M 0.40M 0.04M 0.04M
End period cash flow 2.08M 5.19M 0.04M 0.40M 0.04M
Total cash from operating activities 9.04M -18.22300M 50.20M 9.55M 23.27M
Issuance of capital stock - 0.00000M 0.00000M 2.29M 1.97M
Depreciation 4.90M 4.78M 4.67M 3.81M 2.96M
Other cashflows from investing activities -10.06900M -0.26700M -34.36300M -0.97100M -0.55600M
Dividends paid - 0.00000M 0.00000M 11.60M 0.00000M
Change to inventory - - 9.67M 0.27M 1.77M
Change to account receivables -0.36100M -7.33500M -15.71200M -8.57100M -2.56900M
Sale purchase of stock 1.08M 0.88M -0.06500M -2.68700M -1.97200M
Other cashflows from financing activities 129.50M 124.99M 54.32M 51.77M -13.79300M
Change to netincome 5.88M 11.19M 6.69M 4.95M 3.32M
Capital expenditures 14.17M 6.30M 7.25M 6.71M 3.60M
Change receivables -0.36100M -7.33500M -15.71200M - 0.00000M
Cash flows other operating -13.70400M -25.60700M 22.63M - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes -3.11100M 5.15M -0.35900M - 0.00000M
Change in working capital -9.50400M -37.38200M 22.95M -2.04800M 1.30M
Stock based compensation 3.09M 10.04M 8.34M 3.38M 2.38M
Other non cash items 1.62M 3.94M 0.89M 1.16M 0.94M
Free cash flow -5.12600M -24.52600M 42.95M 2.84M 19.67M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PNTG
Pennant Group Inc
-0.61 2.17% 27.54 43.55 23.64 1.11 4.32 1.71 30.36
HCA
HCA Holdings Inc
0.82 0.27% 299.97 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR
-0.09 1.01% 8.82 16.87 9.44 0.42 0.78 0.79 5.37
FSNUF
Fresenius SE & Co. KGaA
- -% 34.66 16.76 9.62 0.42 0.79 0.78 5.31
JDHIY
JD Health International Inc
- -% 3.81 62.50 35.97 0.30 2.32 0.16 3.90

Reports Covered

Stock Research & News

Profile

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

Pennant Group Inc

1675 East Riverside Drive, Eagle, ID, United States, 83616

Key Executives

Name Title Year Born
Mr. Brent J. Guerisoli Chief Exec. Officer 1981
Mr. John J. Gochnour Pres & COO 1983
Ms. Jennifer L. Freeman CPA Chief Financial Officer 1969
Mr. Derek J. Bunker Chief Investment Officer, Exec. VP & Sec. 1988
Mr. Brian Wayment Pres of Pennant Midwest Home Health & Hospice Operations NA
Mr. Brent J. Guerisoli CEO & Director 1981
Mr. John J. Gochnour President & COO 1983
Ms. Lynette B. Walbom CPA Chief Financial Officer 1977
Mr. Kirk S. Cheney General Counsel & Corporate Secretary NA
Mr. Brian Wayment President of Cornerstone Healthcare NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.